Lifelong Meditech Profile
Key Indicators
- Authorised Capital ₹ 26.00 Cr
- Paid Up Capital ₹ 19.38 Cr
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 54.50 Cr
- Satisfied Charges ₹ 103.39 Cr
- Revenue Growth -1.54%
- Profit Growth -6.60%
- Ebitda -13.06%
- Net Worth 15.35%
- Total Assets 0.21%
About Lifelong Meditech
Lifelong Meditech Private Limited (LMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 19 July 2002 and has a history of 22 years and seven months. Its registered office is in New Delhi, Delhi, India.
The Corporate was formerly known as Welcare Meditech Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 26.00 Cr and a paid-up capital of Rs 19.38 Cr.
The company currently has active open charges totaling ₹54.50 Cr. The company has closed loans amounting to ₹103.39 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Lifelong Meditech Private Limited India is Kanwal Kalra as COMPANY SECRETARY. Hamendra Srivastava, Anil Sachdeva, and Ramabadran Sundararajan serve as directors at the Company.
Company Details
- Location
New Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85110DL2002PTC116251
- Company No.
116251
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 2002
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Lifelong Meditech Private Limited offer?
Lifelong Meditech Private Limited offers a wide range of products and services, including Die Casting & Investment Castings, Casting Parts, Syringes, Auto Disable Syringe, Injection Molding Job Works, Plastic Injection Molding Parts, Medical Tubes, Infusion Sets, Infusion Syringes & Supplies, Disposable Gloves.
Who are the key members and board of directors at Lifelong Meditech?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kanwal Kalra | Company Secretary | 06-Nov-2021 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ramabadran Sundararajan ![]() | Director | 11-Aug-2017 | Current |
Anil Sachdeva ![]() | Additional Director | 20-Jun-2024 | Current |
Hamendra Srivastava ![]() | Whole-Time Director | 21-Sep-2010 | Current |
Financial Performance of Lifelong Meditech.
Lifelong Meditech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.54% decrease. The company also saw a slight decrease in profitability, with a 6.6% decrease in profit. The company's net worth Soared by an impressive increase of 15.35%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Lifelong Meditech?
In 2023, Lifelong Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹54.50 Cr
₹103.39 Cr
Charges Breakdown by Lending Institutions
- Others : 25.00 Cr
- Axis Bank Limited : 15.00 Cr
- Yes Bank Limited : 14.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
30 Nov 2021 | Others | ₹15.00 Cr | Open |
02 Nov 2021 | Axis Bank Limited | ₹15.00 Cr | Open |
29 Jul 2019 | Others | ₹10.00 Cr | Open |
31 Jan 2006 | Yes Bank Limited | ₹14.50 Cr | Open |
11 Aug 2017 | Others | ₹2.70 Cr | Satisfied |
How Many Employees Work at Lifelong Meditech?
Lifelong Meditech has a workforce of 257 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Lifelong Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lifelong Meditech's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.